|
| Press Releases |
|
|
| Wednesday, May 29, 2024 |
|
|
KE Holdings: Capitalizing on Growth in Home Renovation and Furnishing Business and Rental Markets |
| KE Holdings Inc., also known as Beike (NYSE:BEKE; HKEX:2423), the leading integrated online and offline platform for housing transactions and services in China, has reported first-quarter results for 2024. more info >> |
|
| Tuesday, May 28, 2024 |
|
|
Beike Q1 Earnings: Resilient Housing Transaction Performance Amid Market Volatility |
| On May 23, 2024, China's KE Holdings Inc., also known as Beike (NYSE:BEKE; HKEX:2423), released its financial results for the first quarter of 2024. The better-than-expected results show that despite market volatility, the company's core housing transaction services business has demonstrated strong resilience. more info >> |
|
| Thursday, May 12, 2022 |
|
|
贝壳今日香港上市：房产交易服务赛道领跑者 数字化标准化先锋 |
| 随着市场需求的迅猛增长，近年，房产交易服务步入黄金期，在此背景下，贝壳控股有限公司（以下简称“贝壳”）迎来发展良机，不仅拥有出色的业绩记录，且通过线上线下双网驱动、大力发展数字化标准化、提升自主科技实力筑牢行业领先地位，继续引领行业发展。 more info >> |
|
|
貝殼今日香港上市：房產交易服務賽道領跑者 數字化標準化先鋒 |
| 隨著市場需求的迅猛增長，近年，房產交易服務步入黃金期，在此背景下，貝殼控股有限公司（以下簡稱「貝殼」）迎來發展良機，不僅擁有出色的業績記錄，且通過線上線下双网驱动、大力發展數字化標準化、提升自主科技實力築牢行業領先地位，繼續引領行業發展。 more info >> |
|
| Friday, May 6, 2022 |
|
|
回港中概股群星荟萃 贝壳何以孕育出珍珠？ |
| 国际劳动节假期一过，香港IPO市场便传来重磅消息，5月5日，贝壳（NYSE:BEKE）宣布，拟将其A类普通股以介绍形式于港交所主板双重主要上市，并将于2022年5月11日正式交易。高盛及中金担任联席保荐人。 more info >> |
|
|
回港中概股群星薈萃 貝殼何以孕育出珍珠？ |
| 國際勞動節假期一過，香港IPO市場便傳來重磅消息，5月5日，貝殼（NYSE:BEKE）宣布，擬將其A類普通股以介紹形式於港交所主板雙重主要上市，並將於2022年5月11日正式交易。高盛及中金擔任聯席保薦人。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
珠宝双展匯聚逾82,000环球买家
Mar 9, 2025 13:51 HKT/SGT
|
|
|
珠寶雙展匯聚逾82,000環球買家
Mar 9, 2025 13:41 HKT/SGT
|
|
|
Twin jewellery shows attract over 82,000 global buyers
Mar 9, 2025 13:19 HKT/SGT
|
|
|
OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million
Mar 8, 2025 19:40 HKT/SGT
|
|
|
Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation
Mar 8, 2025 19:20 HKT/SGT
|
|
|
uSMART Securities Initiates Coverage on NAAS Technology with a 'Buy' Rating and a Target Price of US$3.2 per ADS, Citing Industry Leadership and Profitability Outlook
Mar 7, 2025 21:26: JST
|
|
|
Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation
Mar 7, 2025 20:31: JST
|
|
|
uSMART Securities Initiates Coverage on NAAS Technology with a 'Buy' Rating and a Target Price of US$3.2 per ADS, Citing Industry Leadership and Profitability Outlook
Mar 7, 2025 20:26 HKT/SGT
|
|
|
雲頂新耀股價創3年新高 AI+mRNA賦能管線重塑估值
Mar 7, 2025 19:24 HKT/SGT
|
|
|
云顶新耀股价创3年新高 AI+mRNA赋能管线重塑估值
Mar 7, 2025 19:16 HKT/SGT
|
|
|
業聚醫療連續四年實現收入增長 達1.64億美元創新高 純利達3,970萬美元 建議派發末期股息每股10港仙
Mar 7, 2025 18:28 HKT/SGT
|
|
|
业聚医疗连续四年实现收入增长 达1.64亿美元创新高 纯利达3,970万美元 建议派发末期股息每股10港仙
Mar 7, 2025 18:10 HKT/SGT
|
|
|
東信營銷科技：中國AI營銷龍頭斬獲多模態雙備案 技術實力獲國家級認證
Mar 7, 2025 17:58 HKT/SGT
|
|
|
东信营销科技：中国AI营销龙头斩获多模态双备案 技术实力获国家级认证
Mar 7, 2025 17:20 HKT/SGT
|
|
|
Japan's Telecommunications Carriers Enhance Disaster Response with On-site Training for Joint Use of Marine Vessels
Mar 7, 2025 16:24 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
